Switch to:
More From Other Websites
Should You Follow the Smart Money Stampede Out of Equity One, Inc. (EQY)? Dec 09 2016
Neurocrine Biosciences to Present at the 2016 BMO Capital Markets Prescription for Success... Dec 07 2016
Hedge Funds Are Dumping CSRA Inc (CSRA) Dec 06 2016
Neurocrine Biosciences Announces INGREZZA™ (valbenazine) Long-Term Data to be Presented at the... Dec 05 2016
Uterine Fibroids Segment May Offer Opportunity for NBIX Dec 02 2016
ETFs with exposure to Neurocrine Biosciences, Inc. : December 2, 2016 Dec 02 2016
Neurocrine Biosciences Pursues Women’s Health Segment with Elagolix Dec 02 2016
NBIX Continues to Study Valbenazine for Tourette Syndrome Dec 02 2016
Why Valbenazine Studies Seem Promising Dec 01 2016
Should You Avoid Navient Corp (NAVI)? Dec 01 2016
Is Neurocrine Biosciences, Inc. (NBIX) a Good Stock to Buy? Dec 01 2016
Valbenazine May Become a Leading Therapy for Tardive Dyskinesia Dec 01 2016
Neurocrine Biosciences (Nasdaq: NBIX) to Ring The Nasdaq Stock Market Opening Bell Dec 01 2016
Why Neurocrine Biosciences May See Higher Losses in 2016 Dec 01 2016
Neurocrine Biosciences, Inc. breached its 50 day moving average in a Bearish Manner : NBIX-US :... Dec 01 2016
Is Pool Corporation (POOL) A Good Stock To Buy? Nov 30 2016
Neurocrine Announces FDA Advisory Committee Meeting to Review INGREZZA™ (valbenazine) New Drug... Nov 29 2016
Elagolix May Become a Strong Growth Driver for AbbVie Nov 29 2016
Coverage initiated on Neurocrine Biosci by Oppenheimer Nov 22 2016
Neurocrine Biosciences to Present at the 28th Annual Piper Jaffray Healthcare Conference Nov 21 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK